根据Gen Consulting公司最新分析, the global neuropathic pain market is poised to grow by USD 9.0 亿期间 2022-2028, 复合年增长率为 6.3% 在预测期内.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global neuropathic pain market. 它追踪市场的历史和预测市场增长. 该报告根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the neuropathic pain industry.

该行业报告提供了全球市场的市场估计和预测, 其次是类型的详细分析, 指示, diagnosis, treatment, 分销渠道, 最终用户, 和地区. The global market for neuropathic pain can be segmented by type: peripheral neuropathy, entrapment neuropathy, trigeminal neuralgia, phantom limb pain, post herpetic neuralgia (PHN), post traumatic neuropathy. The peripheral neuropathy segment captured the largest share of the market in 2021. Neuropathic pain market is further segmented by indication: diabetic neuropathy, spinal stenosis, chemotherapy, 其他的. The diabetic neuropathy segment held the largest share of the global neuropathic pain market in 2021 预计在预测期内将持有其份额. Based on diagnosis, the neuropathic pain market is segmented into: 成像, blood tests, physical examination. 在 2021, the imaging segment made up the largest share of revenue generated by the neuropathic pain market. On the basis of treatment, the neuropathic pain market also can be divided into: medication, multimodal therapy. 在这些当中, the medication segment was accounted for the highest revenue generator in 2021. Neuropathic pain market by distribution channel is categorized into: drug store, 在线的, 其他的. The neuropathic pain market by end user can be segmented into: 医院, 诊所, research center, 其他的. 根据地区, the neuropathic pain market is further categorized into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
按类型: peripheral neuropathy, entrapment neuropathy, trigeminal neuralgia, phantom limb pain, post herpetic neuralgia (PHN), post traumatic neuropathy
按指示: diabetic neuropathy, spinal stenosis, chemotherapy, 其他的
By diagnosis: 成像, blood tests, physical examination
By treatment: medication, multimodal therapy
按分销渠道: drug store, 在线的, 其他的
按最终用户: 医院, 诊所, research center, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The global neuropathic pain market report offers detailed information on several market vendors, including Abbott Laboratories, 阿斯利康公司, Baxter International Inc., Eli Lilly and Company, 葛兰素史克公司, 约翰逊 & 约翰逊, 辉瑞公司, 赛诺菲公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global neuropathic pain market.
– To classify and forecast the global neuropathic pain market based on type, 指示, diagnosis, treatment, 分销渠道, 最终用户, 地区.
– To identify drivers and challenges for the global neuropathic pain market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global neuropathic pain market.
– To identify and analyze the profile of leading players operating in the global neuropathic pain market.

为什么选择这份报告
– Gain a reliable outlook of the global neuropathic pain market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.